Fast food and prostate cancer. Diagnosis of the fourth stage of the “The Office” star; A new group of cancer?

Men who consumed greater amounts of ultra-processed foods had a higher risk of developing cancer Development of prostate cancer In a large study. (Florida Atlantic University)

Maura Jellison, MD, PhD, is credited with proving the link between HPV and head and neck cancer, He died at the age of 61 From small intestine cancer. (New York Times)

Federal Court of Appeals It overturned the 2024 dismissal of a $6.7 billion lawsuit Which accused Bristol-Myers Squibb of deceiving former Celgene shareholders by delaying FDA approval of its CAR T-cell therapy T-lisocabtagene maraleucel (Breyanzi), which now has indications for lymphoma and leukemia. (Pharma is fierce)

Food and Drug Administration Deny consent Investigational radionuclide therapy ¹⁷⁷Lo-edotreotide is used to treat neuroendocrine tumors of the gastrointestinal tract and pancreas due to manufacturing problems, the manufacturer, Isotop Technologies Munich, said.

In a phase III trial, first-line treatment with Investigational targeted therapy Zipalertinib Combined with platinum-based chemotherapy resulted in significant improvement in progression-free survival in non-small cell lung cancers with EGFR Taiho Oncology announced exon 20 insertions.

Actress Lucy Davis, best known for her roles in the original British version of The Office and Shaun of the Dead, has revealed… Stage IV breast cancer. (New York Times)

Residents of two New Jersey cities want more information about A Potential cancer mass After more than 400 cases were reported – including dozens in one street. (NBC New York)

Patients with metastatic castration-sensitive prostate cancer whose prostate-specific antigen levels were less than 0.2 ng/mL within 9 months of starting treatment had improvement. Overall survivalsuggested a retrospective analysis. (cancer)

Stereotactic body radiotherapy improved bowel-related quality of life compared with moderately hypofractionated intensity-modulated radiotherapy among men with intermediate-risk prostate cancer, but It did not improve 3-year disease-free survivalI found a randomized trial. (Gamma)

Traditional pathological features used to classify aggressive prostate cancer after surgery can help identify patients who are more likely to have worse outcomes, but Don’t expect who will benefit More than adding hormonal therapy to postoperative radiation, a meta-analysis of five randomized trials showed. (University of California Health)

In the case of colorectal cancer, the obesity paradox—patients with a higher BMI showing a better survival rate—could be Due to cancer-related weight loss before diagnosisaccording to a case-control study. (The JAMA Network is open)

Researchers are working on tissue chip technology to predict cancer immunotherapies Harmful immune reactions may result. (University of Rochester)